Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Not Applicable
Suspended
- Conditions
- DVTAnti-coagulation TherapyAtrial FibrillationJoint Surgery MultiplePulmonary EmbolismProsthetic Replacement of Mitral Valve
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2015-08-31
- Lead Sponsor
- Iverson Genetic Diagnostics, Inc.
- Target Recruit Count
- 3800
- Registration Number
- NCT01305148
- Locations
- 🇺🇸
Veterans' Affairs Medical Center, Birmingham, Alabama, United States
🇺🇸Cardiovascular Consultants - Thunderbird, Glendale, Arizona, United States
🇺🇸Cardiovascular Consultants - Phoenix, Phoenix, Arizona, United States